Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underutilization of surgery

Surgery may be underutilized for stage IIIA non-small cell lung cancer (NSCLC). Although an argument can be made for definitive chemoradiation (dCRT) for N2/3 mediastinal nodal disease, the role of a nonsurgical strategy is less clear in cT3N1M0 stage IIIA patients given a lack of randomized data. We therefore sought to determine outcomes of cT3N1M0 patients by treatment type from the National Cancer Database (NCDB).

https://www.jtcvs.org/article/S0022-5223(20)30503-1/fulltext?rss=yes

Source: The Journal of Thoracic and Cardiovascular Surgery - February 23, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Mohamed Rahouma, Mohamed Kamel, Abu Nasar, Sebron Harrison, Benjamin Lee, Jeffrey Port, Nasser Altorki, Brendon M. Stiles Source Type: research